| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.031 | 0.5 |